← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 10, 2004Last known activity
Mar 1, 2024
Timeline
2000s
- Jun 1, 2002
Oncotherapeutics— Founded
Drugs by trial phase (22 distinct, 21 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (32)
- NCT06225310Lead sponsorPhase 1Mar 1, 2024
- NCT06115135Lead sponsorPhase 2Dec 1, 2023
- NCT04519476Lead sponsorPhase 1Nov 1, 2020
- NCT04519476Overall official - principal investigatorPhase 1Nov 1, 2020
- NCT03733691Lead sponsorPhase 2Dec 20, 2018
- NCT03733691Overall official - principal investigatorPhase 2Dec 20, 2018
- NCT03733691Sponsor investigatorPhase 2Dec 20, 2018
- NCT03104270Overall official - principal investigatorPhase 2Mar 13, 2017
- NCT03104270Lead sponsorPhase 2Mar 13, 2017
- NCT03110822Lead sponsorPhase 1Feb 6, 2017
- NCT03110822Overall official - principal investigatorPhase 1Feb 6, 2017
- NCT02294357Lead sponsorPhase 2Dec 1, 2014
- NCT02285101CollaboratorPhase 1Nov 1, 2014
- NCT02206425Lead sponsorPhase 1/Phase 2Sep 1, 2014
- NCT02188368Lead sponsorPhase 2Aug 1, 2014
Details
- Founded
- West Hollywood, CA, US Jun 1, 2002
- Last known activity
- Mar 1, 2024
Notes
CRO